PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34471797-7	2021	Conclusions: Within the limitations of a small sample size, there was a strong effect of introducing two interventions (a case-based orientation and a nudging system) upon EPA assessments with PGY-1 residents.	Eicosapentaenoic Acid	172-175	ATP binding cassette subfamily B member 1	Homo sapiens	193-198	
29492971-8	2018	Arachidonic acid (AA), docosahexaenoic acid (DHA) and eicosapentenoic acid (EPA) significantly decreased P-GP activity without affecting expression or membrane fluidity.	Eicosapentaenoic Acid	76-79	ATP binding cassette subfamily B member 1	Homo sapiens	105-109	
29492971-9	2018	AA, DHA and EPA counteracted IL-1beta-mediated increases in P-GP activity, while AA and EPA, but not DHA, counteracted glucocorticoid-mediated increase in P-GP activity.	Eicosapentaenoic Acid	12-15	ATP binding cassette subfamily B member 1	Homo sapiens	60-64	
29492971-9	2018	AA, DHA and EPA counteracted IL-1beta-mediated increases in P-GP activity, while AA and EPA, but not DHA, counteracted glucocorticoid-mediated increase in P-GP activity.	Eicosapentaenoic Acid	88-91	ATP binding cassette subfamily B member 1	Homo sapiens	155-159